ANAB 8-K 2026-09-21

ANAPTYSBIO, INC (ANAB) 8-K dated 2026-09-21 — accession 0001193125-26-396690. This URL is the filing, not the ANAB hub.

ANAPTYSBIO, INC (ANAB) is a biotechnology company listed on NASDAQ.

ANAPTYSBIO, INC filed a 8-K on 2026-09-21. Accession 0001193125-26-396690.

Cached items: 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ANAB revenue for 2026-03-31 was $25.6M. Net income was -$52.9M. Revenue was down 66.5% from 2025-09-30 to 2026-03-31. ANAB currently screens at market cap $1.62B.

Not investment advice. The ANAB SEC hub lists recent forms. The stock page is the research view.